Joseph Schwartz

Sep 18, 2026

Joseph Schwartz rated ELOX as Outperform on Sep 18, 2026, setting a price target of 32. Shares have remained stable near 17.55, leaving the 32 target still in play.

Sep 14, 2026

On Sep 14, 2026, LRMR was given a Outperform rating by Joseph Schwartz, with a target price of 13. The stock traded sideways with a 0.53% move, keeping the bullish thesis unresolved.

Jul 28, 2026

GOSS received a Outperform rating from Joseph Schwartz on Jul 28, 2026, aiming for 1. The rating hasn’t played out as hoped, with the stock trading 27.23% below expectations.

Jun 24, 2026

On Jun 24, 2026, Joseph Schwartz published a Outperform outlook on QNCX, with a target of 4. Shares gained 41.90%, underscoring the accuracy of the bullish outlook toward 4.

Jun 18, 2026

Joseph Schwartz on Jun 18, 2026 assigned QURE a Outperform rating, with a price target of 70. The recommendation remains pending validation as shares consolidate around 44.09.

May 15, 2026

RNA was rated Outperform by Joseph Schwartz on May 15, 2026, with a price objective of 25. This case shows how bullish projections can fail, with the stock now below 9.56.

May 14, 2026

On May 14, 2026, Joseph Schwartz initiated coverage on ANTX with a Outperform rating and target of 9. The stock’s climb of 5.60% since the call highlights the foresight in the rating.

Apr 06, 2026

Joseph Schwartz issued a Outperform recommendation for MSLE on Apr 06, 2026, price target set at 20. Investors following the Buy call captured upside momentum, with shares now at 9.68.

Mar 24, 2026

On Mar 24, 2026, INSM was evaluated by Joseph Schwartz, who gave a Outperform rating and target of 215. Investors saw limited payoff as shares fell short of the 215 target.

Dec 30, 2025

Joseph Schwartz rated RARE as Outperform on Dec 30, 2025, setting a price target of 80. The stock has underperformed, dropping 36.35% despite the bullish target of 80.

Dec 03, 2025

SPRB received a Outperform rating from Joseph Schwartz on Dec 03, 2025, aiming for 160. The rating hasn’t played out as hoped, with the stock trading 40.26% below expectations.

Dec 03, 2025

DSGN was rated Outperform by Joseph Schwartz on Dec 03, 2025, with a price objective of 14. A bullish response from the market helped close the gap of 1.19 to the target.

Nov 10, 2025

Joseph Schwartz issued a Outperform recommendation for MNPR on Nov 10, 2025, price target set at 115. Investors following the Buy call captured upside momentum, with shares now at 102.7.

Sep 29, 2025

On Sep 29, 2025, CRNX was evaluated by Joseph Schwartz, who gave a Outperform rating and target of 88. This case illustrates how a timely bullish rating can translate into tangible gains of 95.24%.

Jul 07, 2025

On Jul 07, 2025, KALV was given a Outperform rating by Joseph Schwartz, with a target price of 20. The stock rallied 79.28% after the rating, narrowing the gap to the target of 20 and validating the bullish stance.

Feb 25, 2025

On Feb 25, 2025, Joseph Schwartz published a Outperform outlook on MAZE, with a target of 28. Shares gained 121.76%, underscoring the accuracy of the bullish outlook toward 28.

Oct 11, 2024

Joseph Schwartz on Oct 11, 2024 assigned TVTX a Outperform rating, with a price target of 40. The Buy call aligned well with market performance, producing a gain of 294.52%.

Jun 24, 2024

On Jun 24, 2024, Joseph Schwartz reaffirmed SLDB with a Outperform rating, targeting 12. The recommendation was supported by strong follow-through as the stock rose from 8.87 to 8.87.

Jun 20, 2024

MREO was rated Outperform by Joseph Schwartz on Jun 20, 2024, with a price objective of 8. This case shows how bullish projections can fail, with the stock now below 0.2901.